Driehaus Capital Management is an independent boutique investment adviser managing long-only equity and multi-asset alternative strategies. With over 40 years of experience, the company offers a range of growth equity and liquid alternative investment solutions to institutional and individual investors. Founded in 1982 by Richard H. Driehaus, the firm is known for its disciplined, performance-driven approach, leveraging integrity and an entrepreneurial spirit.
Recent Transactions involving Driehaus Capital Management
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics |
Spyre Therapeutics |
Aeglea BioTherapeutics |
EcoR1 CapitalFairmount Funds ManagementVenrock Healthcare Capital PartnersCommodore CapitalPerceptive AdvisorsRTW InvestmentsCormorant Asset ManagementDriehaus Capital ManagementSurveyor CapitalWellington Management CompanyUndisclosed Institutional InvestorsFidelity Management and ResearchRA Capital ManagementDeepTrack Capital |
Biotechnology Research |
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →